Boston Innovation Meets ADME Precision

Smarter ADME Screening. Flexible Bundle. Greater Confidence. Flexible Screening Panels That Evolve With Your Pipeline. We get it – early discovery is fast-moving and complex. That’s why our bundled in vitro ADME panels are designed for your workflow, whether you choose one, two, or a full suite. Speed, Clarity, and Tailored Flexibility. and we are […]

Medicilon—Developing PDX-Derived Organoid Models for Efficacy Evaluation of Anticancer Therapies (Download)

PDX-derived organoids combine the genetic fidelity of patient tumors with the scalability and speed of in vitro platforms—delivering a powerful model for evaluating therapeutic response. These models enable:🔷 More accurate efficacy prediction🔷 Reduced translational gaps🔷 Faster iteration for lead optimization This approach strengthens the bridge between preclinical data and clinical outcomes—empowering oncology researchers to make […]

Search Medicilon

Meet Medicilon at Nordic PMF 2026

Nordic PMF 2026

Preclinical CRO

AACR 2026 Special Report: An In-Depth Review of Medicilon’s Three Technical Posters | Bilingual

Meet Medicilon at ICDD 2026

ICDD 2026

Contact Medicilon

Name(Required)
Address(Required)